HOME › DRUGS › ERENUMAB
ACTIVE SUBSTANCE / INN

ERENUMAB

Brand name(s): Aimovig
EMA LISTED
AUTHORISED
Migraine Disorders
ACTIVE SUBSTANCE
Erenumab
REGULATORS
EMA
SPONSORS / MAH
Novartis Europharm Limited
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
AimovigNovartis Europharm LimitedAuthorised26/07/2018Migraine Disorders

FULL INTELLIGENCE ON ERENUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →